DGAP-News: PAION AG / Key word(s): Miscellaneous
PAION AG: PLANNED TRANSITION IN PRIME STANDARD COMPLETED
07.04.2014 / 13:30
---------------------------------------------------------------------
PLANNED TRANSITION IN PRIME STANDARD COMPLETED
Aachen (Germany), 07 April 2014 - The biopharmaceutical company PAION AG
(ISIN DE000A0B65S3; Frankfurt Stock Exchange Prime Standard: PA8) received
admission to the sub-segment of the regulated market of the Frankfurt Stock
Exchange with additional listing obligations (Prime Standard) effective 7
April 2014 by Deutsche Börse AG.
The change to the Prime Standard is intended to increase the attractiveness
of PAION shares and strengthens its position vis-Ã -vis international
investors through compliance with the highest transparency requirements.
The company thus also fulfils one of the requirements for a possible
inclusion in a selection index of Deutsche Börse AG.
###
About PAION
PAION AG is a publicly-listed biopharmaceutical company headquartered in
Aachen, Germany with a second site in Cambridge, UK. The company has a
track record in developing hospital-based treatments for which there is
substantial unmet medical need. PAION AG is transforming its business model
from a pure development company to a specialty pharmaceutical company with
a focus on anaesthesia products to take advantage of the unique profile of
its main compound, Remimazolam.
Contact
Ralf Penner
Director Investor Relations / Public Relations
PAION AG
Martinstrasse 10-12
52062 Aachen - Germany
Phone: +49 241 4453-152
E-mail: r.penner@paion.com
www.paion.com
Disclaimer:
This release contains certain forward-looking statements concerning the
future business of PAION AG. These forward-looking statements contained
herein are based on the current expectations, estimates and projections of
PAION AG's management as of the date of this release. They are subject to a
number of assumptions and involve known and unknown risks, uncertainties
and other factors. Should actual conditions differ from the Company's
assumptions, actual results and actions may differ materially from any
future results and developments expressed or implied by such
forward-looking statements. Considering the risks, uncertainties and other
factors involved, recipients should not rely unreasonably upon these
forward-looking statements. PAION AG has no obligation to periodically
update any such forward-looking statements to reflect future events or
developments.
End of Corporate News
---------------------------------------------------------------------
07.04.2014 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: PAION AG
Martinstr. 10-12
52062 Aachen
Germany
Phone: +49 (0)241-4453-0
Fax: +49 (0)241-4453-100
E-mail: info@paion.com
Internet: www.paion.com
ISIN: DE000A0B65S3
WKN: A0B65S
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, München,
Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
261934 07.04.2014
DGAP-News: PAION AG: PLANNED TRANSITION IN PRIME STANDARD COMPLETED
| Source: EQS Group AG